Product image of Lenalidomide Norameda (Lenalidomide) supplied by GNH India

Lenalidomide Norameda

Active Ingredient:
Lenalidomide
Origin:
EU

Lenalidomide Norameda (Lenalidomide)

Lenalidomide, the active ingredient in Lenalidomide Norameda, is an immunomodulatory imide drug presented as a tablet for oral use. It is employed in the treatment of multiple myeloma and myelodysplastic syndromes in adult patients, modulating immune response and inhibiting angiogenesis to help control disease progression.

GNH India supplies Lenalidomide Norameda as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution through established supply chains.

Manufacturer / TM Owner

Norameda Uab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lenalidomide is an immunomodulatory agent used in hematologic malignancies and bone‑marrow failure disorders.

  • Multiple Myeloma: improves progression‑free survival and overall response rates in newly diagnosed or relapsed disease.
  • Myelodysplastic Syndromes with del(5q): reduces transfusion dependence and can induce cytogenetic remission.
  • Relapsed or refractory Multiple Myeloma: extends overall survival when combined with dexamethasone or other agents.

How It Works

  • Lenalidomide binds to the cereblon component of the CRL4‑CRBN E3 ubiquitin ligase complex, triggering ubiquitination and proteasomal degradation of transcription factors Ikaros and Aiolos. This leads to altered cytokine production, enhanced natural killer and T‑cell activity, and inhibition of angiogenesis, collectively exerting antineoplastic effects in target cells.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Fatigue: persistent tiredness reported by many patients.
  • Neutropenia: reduced neutrophil count increasing infection risk.
  • Diarrhea: loose stools that may require supportive care.
  • Rash: skin eruptions ranging from mild to moderate.
  • Anemia: lowered red blood cell levels causing weakness.
  • Nausea: occasional upset stomach.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins or lungs.
  • Severe neutropenia or thrombocytopenia: markedly low blood cell counts.
  • Secondary primary malignancies: emergence of new cancers.
  • Hypersensitivity reactions: including Stevens‑Johnson syndrome.
  • Hepatotoxicity: elevated liver enzymes indicating liver injury.
  • Embryo‑fetal toxicity: potential harm to developing fetus.

Precautions & Warnings

Careful monitoring and patient counseling are essential before and during therapy.

  • Blood count monitoring: perform complete blood counts regularly to detect cytopenias.
  • Thromboembolic risk assessment: evaluate need for prophylactic anticoagulation in high‑risk patients.
  • Renal function evaluation: adjust therapy if severe renal impairment is present.
  • Contraception requirement: ensure effective birth control for patients of reproductive potential.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Lenalidomide may interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Anticoagulants: increased bleeding risk when combined with warfarin or direct oral anticoagulants.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise lenalidomide exposure and toxicity.
  • Potent CYP3A4 inducers (e.g., rifampicin): can lower drug levels, reducing efficacy.

Moderate Interactions (Monitor Closely)

  • Immunosuppressants (e.g., cyclosporine): may enhance immunosuppression.
  • Live vaccines: risk of infection due to immune modulation.
  • NSAIDs: additive risk of gastrointestinal bleeding and cytopenias.

Frequently Asked Questions

Lenalidomide Norameda is indicated for the treatment of multiple myeloma and for myelodysplastic syndromes that carry a deletion of chromosome 5q. In both settings it helps control disease progression by modulating the immune system and inhibiting abnormal cell growth.

The drug binds to cereblon, a component of an E3 ubiquitin ligase complex, leading to the degradation of transcription factors Ikaros and Aiolos. This triggers changes in cytokine production, boosts natural killer and T‑cell activity, and blocks new blood‑vessel formation, collectively producing antitumor effects.

The specific dose and schedule are determined by the prescribing clinician based on the patient’s diagnosis, disease stage, renal function, and other individual factors. No universal dosing regimen is provided here; the prescriber will tailor therapy to each case.

Safety data are limited, and animal studies suggest a risk of fetal harm. Lenalidomide is generally contraindicated in pregnancy, and effective contraception is required for women of child‑bearing potential. Breastfeeding is not recommended while receiving the medication.

To request Lenalidomide Norameda, submit an enquiry on the product page at gnhindia.com with the desired quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lenalidomide belongs to the IMiD class, similar to thalidomide and pomalidomide. Compared with thalidomide, it typically shows lower neuropathy rates and stronger anti‑angiogenic activity. Pomalidomide is a newer IMiD with higher potency but may carry a different safety profile. Choice depends on disease specifics, prior therapy and tolerability.

Store the tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Do not refrigerate or freeze. Keep out of reach of children and handle according to standard pharmaceutical safety practices.

The medication is taken orally as a tablet, usually with or without food as directed by the prescriber. Swallow the tablet whole with water; do not crush or split unless specifically instructed. Adherence to the prescribed schedule is important for optimal therapeutic effect.

Key serious risks include venous thromboembolism (blood clots), severe neutropenia or thrombocytopenia (dangerously low white‑blood‑cell or platelet counts), and the potential development of secondary primary malignancies. Patients should be monitored closely for signs of infection, bleeding, or new cancer symptoms.

Lenalidomide is contraindicated in individuals with known hypersensitivity to the drug or any of its components. It should be avoided in patients who are pregnant, not using effective contraception, or who have severe renal impairment without dose adjustment. Clinicians must evaluate each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lenalidomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT